Abstract
2-methoxyestradiol (2-MeOE2) treatment caused significant growth inhibition of H460 and A549 human lung cancer cell lines which contain wild-type p53. However, 2-MeOE2 had a little effect on the p53 negative H358 and p53 mutated H322 cell lines. Western blot analysis indicated that 2-MeOE2 treatment resulted in an eightfold increase in the endogenous wild-type p53 protein, while the level of the mutant p53 protein remained unchanged. TdT staining indicated that following 2-MeOE2-mediated increases in wildtype p53 protein, cells bypass the G1-S checkpoint of the cell cycle with 30 to 40% undergoing apoptosis. Introduction of anti-sense wt-p53 into wt-p53 cells abrogated the 2-MeOE2 effect. A significant portion of lung cancer retains the wild-type p53 gene therefore, 2-MeOE2 may have therapeutic application.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mukhopadhyay, T., Roth, J. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 14, 379–384 (1997). https://doi.org/10.1038/sj.onc.1200835
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1200835
Keywords
This article is cited by
-
An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia
Cancer Cell International (2017)
-
An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study
Cancer Cell International (2014)
-
p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
Nature Communications (2013)
-
Combination treatment with 2-methoxyestradiol overcomes bortezomib resistance of multiple myeloma cells
Experimental & Molecular Medicine (2013)
-
The Association Between a Functional CYP1A1 Polymorphism and Colorectal Neoplasia Risk in Post Menopausal Women
Digestive Diseases and Sciences (2010)